Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07343908 · ClinicalTrials.gov registry record · NA
Impact of Chia Seeds on Human Breast Milk Composition
A NA study, sponsored by University of Oklahoma.
- Not yet
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT07343908 is a NA study that has not yet begun recruiting, run by University of Oklahoma. The registered enrollment target is 80 participants.
The verdict
NCT07343908, a NA study, has not yet begun recruiting, sponsored by University of Oklahoma.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The investigators' over-arching hypothesis is that mechanical and compositional properties of chia seeds supplemented during lactation diminish obesity-induced intestinal inflammation and barrier dysfunction. The investigators hypothesize these changes will result in: 1) reduced maternal systemic inflammation (serum CRP and IL-6) and increased gut microbial diversity and richness, 2) reduced HM fat and inflammatory markers, metrics the research team have demonstrated differ in tandem with maternal metabolic health and 3) improved infant growth/body composition. To test these hypotheses, investigators will evaluate chia seed supplementation during lactation in a 6wk multi-site pilot RCT (Aim 1) and through translational studies using human enteroids (Aim 2).
Interventions
- DIETARY_SUPPLEMENT Chia seeds
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-08 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07343908
The ClinicalTrials.gov registry entry for NCT07343908 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chia seeds is the first listed.
NCT07343908 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07343908 about?
NCT07343908 is a clinical study titled "Impact of Chia Seeds on Human Breast Milk Composition". The investigators' over-arching hypothesis is that mechanical and compositional properties of chia seeds supplemented during lactation diminish obesity-induced intestinal inflammation and barrier dysfunction. The investigators hypothesize these changes will result in: 1) reduced maternal systemic in...
What is the current status of trial NCT07343908?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-08. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07343908?
The interventions under investigation include: Chia seeds (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07343908?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.